Content matching 'world stem cell summit'
Features discussions related to the Capital Markets and finances aspect of the regenerative medicine industry
Latest developments compiled from 01 – 31 December 2014
Cell therapy weekly: Roche acquires MS program and GvHD therapy receives Orphan Drug Designation
Peek behind the paper: Preparing regenerative therapies for clinical application: proposals for responsible translation